(Q34874626)

5 August 2017

Dose response effect of high-dose fluconazole for HIV-associated cryptococcal meningitis in southwestern Uganda (English)

1 reference

5 August 2017

0 references

1 reference

1 reference

cryptococcal meningitis

1 reference

Emma Wall

7

0 references

Thomas Harrison

object named as

Thomas S Harrison

10

0 references

Shabbar Jaffar

object named as

Shabbar Jaffar

9

0 references

Conrad Muzoora

2

object named as

Conrad Muzoora

1 reference

5 August 2017

Nicky Longley

1

1 reference

5 August 2017

Kabanda Taseera

3

1 reference

5 August 2017

James Mwesigye

4

1 reference

5 August 2017

Joselyne Rwebembera

5

1 reference

5 August 2017

Ali Chakera

6

1 reference

5 August 2017

Irene Andia

8

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 December 2008

1 reference

Clinical Infectious Diseases

5 August 2017

1 reference

5 August 2017

47

1 reference

5 August 2017

12

1 reference

5 August 2017

1556-1561

1 reference

Antiretroviral roll-out, antifungal roll-back: access to treatment for cryptococcal meningitis

5 August 2017

1 reference

Clinical presentation, natural history, and cumulative death rates of 230 adults with primary cryptococcal meningitis in Zambian AIDS patients treated under local conditions

21 January 2018

1 reference

Outcome of AIDS-associated cryptococcal meningitis initially treated with 200 mg/day or 400 mg/day of fluconazole

21 January 2018

1 reference

Symptomatic relapse of HIV-associated cryptococcal meningitis after initial fluconazole monotherapy: the role of fluconazole resistance and immune reconstitution.

21 January 2018

1 reference

Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial

21 January 2018

1 reference

High-dose fluconazole therapy for cryptococcal meningitis in patients with AIDS.

21 January 2018

1 reference

Safety, plasma concentrations, and efficacy of high-dose fluconazole in invasive mold infections.

21 January 2018

1 reference

Fluconazole alone or combined with flucytosine for the treatment of AIDS-associated cryptococcal meningitis.

21 January 2018

1 reference

Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America

21 January 2018

1 reference

Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial

21 January 2018

1 reference

High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial

21 January 2018

1 reference

Pharmacokinetics and pharmacodynamics of antifungals

21 January 2018

1 reference

High-dose fluconazole therapy in patients with severe fungal infections

21 January 2018

1 reference

21 January 2018

Coccidioidal meningitis

1 reference

The medical management of central nervous system infections in Uganda and the potential impact of an algorithm-based approach to improve outcomes

21 January 2018

1 reference

Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy

21 January 2018

1 reference

Plasma nevirapine levels, adverse events and efficacy of antiretroviral therapy among HIV-infected patients concurrently receiving nevirapine-based antiretroviral therapy and fluconazole

21 January 2018

1 reference

Fungal Burden, Early Fungicidal Activity, and Outcome in Cryptococcal Meningitis in Antiretroviral-Naive or Antiretroviral-Experienced Patients Treated with Amphotericin B or Fluconazole

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/593194

1 reference

5 August 2017

1 reference